Matches in SemOpenAlex for { <https://semopenalex.org/work/W4283269550> ?p ?o ?g. }
- W4283269550 endingPage "206" @default.
- W4283269550 startingPage "191" @default.
- W4283269550 abstract "Liver fibrosis is a wound-healing response that results from various chronic damages. If the causes of damage are not removed or effective treatments are not given in a timely manner, it will progress to cirrhosis, even liver cancer. Currently, there are no specific medical therapies for liver fibrosis. Adeno-associated virus (AAV)-mediated gene therapy, one of the frontiers of modern medicine, has gained more attention in many fields due to its high safety profile, low immunogenicity, long-term efficacy in mediating gene expression, and increasingly known tropism. Notably, increasing evidence suggests a promising therapeutic potential for AAV-mediated gene therapy in different liver fibrosis models, which helps to correct abnormally changed target genes in the process of fibrosis and improve liver fibrosis at the molecular level. Moreover, the addition of cell-specific promoters to the genome of recombinant AAV helps to limit gene expression in specific cells, thereby producing better therapeutic efficacy in liver fibrosis. However, animal models are considered to be powerless predictive of tissue tropism, immunogenicity, and genotoxic risks in humans. Thus, AAV-mediated gene therapy will face many challenges. This review systemically summarizes the recent advances of AAV-mediated gene therapy in liver fibrosis, especially focusing on cellular and molecular mechanisms of transferred genes, and presents prospective challenges. Liver fibrosis is a wound-healing response that results from various chronic damages. If the causes of damage are not removed or effective treatments are not given in a timely manner, it will progress to cirrhosis, even liver cancer. Currently, there are no specific medical therapies for liver fibrosis. Adeno-associated virus (AAV)-mediated gene therapy, one of the frontiers of modern medicine, has gained more attention in many fields due to its high safety profile, low immunogenicity, long-term efficacy in mediating gene expression, and increasingly known tropism. Notably, increasing evidence suggests a promising therapeutic potential for AAV-mediated gene therapy in different liver fibrosis models, which helps to correct abnormally changed target genes in the process of fibrosis and improve liver fibrosis at the molecular level. Moreover, the addition of cell-specific promoters to the genome of recombinant AAV helps to limit gene expression in specific cells, thereby producing better therapeutic efficacy in liver fibrosis. However, animal models are considered to be powerless predictive of tissue tropism, immunogenicity, and genotoxic risks in humans. Thus, AAV-mediated gene therapy will face many challenges. This review systemically summarizes the recent advances of AAV-mediated gene therapy in liver fibrosis, especially focusing on cellular and molecular mechanisms of transferred genes, and presents prospective challenges." @default.
- W4283269550 created "2022-06-23" @default.
- W4283269550 creator A5004165941 @default.
- W4283269550 creator A5005103669 @default.
- W4283269550 creator A5018124690 @default.
- W4283269550 creator A5038545320 @default.
- W4283269550 creator A5051221459 @default.
- W4283269550 creator A5062469302 @default.
- W4283269550 creator A5073843110 @default.
- W4283269550 creator A5085878237 @default.
- W4283269550 date "2022-09-01" @default.
- W4283269550 modified "2023-10-17" @default.
- W4283269550 title "Emerging therapeutic potential of adeno-associated virus-mediated gene therapy in liver fibrosis" @default.
- W4283269550 cites W1487084354 @default.
- W4283269550 cites W149497181 @default.
- W4283269550 cites W1510312340 @default.
- W4283269550 cites W1575532392 @default.
- W4283269550 cites W1953619806 @default.
- W4283269550 cites W1963694788 @default.
- W4283269550 cites W1965588383 @default.
- W4283269550 cites W1968006472 @default.
- W4283269550 cites W1969271703 @default.
- W4283269550 cites W1970136916 @default.
- W4283269550 cites W1974168476 @default.
- W4283269550 cites W1978182359 @default.
- W4283269550 cites W1990768683 @default.
- W4283269550 cites W1993345123 @default.
- W4283269550 cites W2001430685 @default.
- W4283269550 cites W2007832228 @default.
- W4283269550 cites W2008399598 @default.
- W4283269550 cites W2011436699 @default.
- W4283269550 cites W2013395288 @default.
- W4283269550 cites W2025343661 @default.
- W4283269550 cites W2032121833 @default.
- W4283269550 cites W2041572370 @default.
- W4283269550 cites W2047667011 @default.
- W4283269550 cites W2053375184 @default.
- W4283269550 cites W2071404720 @default.
- W4283269550 cites W2075953769 @default.
- W4283269550 cites W2076486071 @default.
- W4283269550 cites W2077117772 @default.
- W4283269550 cites W2083068177 @default.
- W4283269550 cites W2084074847 @default.
- W4283269550 cites W2089401171 @default.
- W4283269550 cites W2091134968 @default.
- W4283269550 cites W2092445818 @default.
- W4283269550 cites W2093024396 @default.
- W4283269550 cites W2095297471 @default.
- W4283269550 cites W2097059462 @default.
- W4283269550 cites W2110999558 @default.
- W4283269550 cites W2114929846 @default.
- W4283269550 cites W2125386672 @default.
- W4283269550 cites W2125784153 @default.
- W4283269550 cites W2131534367 @default.
- W4283269550 cites W2133112334 @default.
- W4283269550 cites W2142695353 @default.
- W4283269550 cites W2145365087 @default.
- W4283269550 cites W2147515973 @default.
- W4283269550 cites W2153140538 @default.
- W4283269550 cites W2167224247 @default.
- W4283269550 cites W2294635082 @default.
- W4283269550 cites W2398306036 @default.
- W4283269550 cites W2417472814 @default.
- W4283269550 cites W2521180178 @default.
- W4283269550 cites W2613460655 @default.
- W4283269550 cites W2622051837 @default.
- W4283269550 cites W2727482182 @default.
- W4283269550 cites W2736065260 @default.
- W4283269550 cites W2764182566 @default.
- W4283269550 cites W2765253110 @default.
- W4283269550 cites W2767975206 @default.
- W4283269550 cites W2773253161 @default.
- W4283269550 cites W2773565340 @default.
- W4283269550 cites W2774511679 @default.
- W4283269550 cites W2775538622 @default.
- W4283269550 cites W2776677355 @default.
- W4283269550 cites W2780354185 @default.
- W4283269550 cites W2780464804 @default.
- W4283269550 cites W2792391363 @default.
- W4283269550 cites W2794330007 @default.
- W4283269550 cites W2842475511 @default.
- W4283269550 cites W2890324251 @default.
- W4283269550 cites W2891186944 @default.
- W4283269550 cites W2895074874 @default.
- W4283269550 cites W2906210096 @default.
- W4283269550 cites W2906264678 @default.
- W4283269550 cites W2913212173 @default.
- W4283269550 cites W2914018310 @default.
- W4283269550 cites W2917733137 @default.
- W4283269550 cites W2951934820 @default.
- W4283269550 cites W2959256911 @default.
- W4283269550 cites W2970419481 @default.
- W4283269550 cites W2972588675 @default.
- W4283269550 cites W2976965891 @default.
- W4283269550 cites W2980024488 @default.
- W4283269550 cites W2982807614 @default.
- W4283269550 cites W2989567859 @default.
- W4283269550 cites W2995820186 @default.